Web1 mar. 2024 · Evofem Biosciences, Inc. Q4 2024 Results Earnings Conference Call March 1, 2024 11:00 AM ET. Company Participants. Amy Raskopf - IR. Saundra Pelletier - … WebSaundra Pelletier is the Chief Executive Officer, President and Executive Director of Evofem Biosciences, Inc. Since joining the Company in 2015, Ms. Pelletier has been responsible for Evofem’s rapid growth and evolution, including the Company’s transition to the public market in January 2024 and multiple equity financing rounds that have raised in excess …
Evofem Biosciences Appoints Interim Chief Financial Officer
WebJay File, CFO for Evofem Biosciences, has over 20 years of diverse accounting and finance experience. His prior experience included providing consulting services to various early … WebEvofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of … red interfaces
Jay File - Wiki Golden
WebExhibit 10.55 . FIRST AMENDMENT TO . SUBLEASE . This FIRST AMENDMENT TO SUBLEASE (this “Amendment”) is made and entered into as of February 22, 2024, by and between EVOFEM, INC., a Delaware corporation (“Sublandlord”), and WOMANCARE GLOBAL TRADING INC., a Delaware corporation (“Subtenant”), and amends that certain … Web7 mar. 2024 · Jay File, Chief Financial Officer Linkedin Jenny Yip, Director Alex Fitzpatrick, Executive Vice President, General Counsel and Secretary Linkedin and 6 others Locations View all 1 location detected San Diego, CA HQ United States 12400 High Bluff Dr Report incorrect company information Evofem Biosciences Financials Summary financials WebEvofem Biosciences Inc (EVFM) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. Top Stocks Top Analyst StocksTop Smart Score StocksTop Insiders Stocks Popular Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener … red intercambia